Skip to main content
ABT
NYSE Life Sciences

雅培公司公布2026年第一季度财务结果并更新预期指导，反映了Exact Sciences的收购

feedReported by Dow Jones Newswires
Sentiment info
Neutral
Importance info
7
Price
$99.9
Mkt Cap
$176.883B
52W Low
$99.05
52W High
$139.06
Market data snapshot near publication time

summarizeSummary

雅培实验室已经宣布其2026年第一季度财务结果。最重要的是，该公司还提供了更新的财务指导，明确指出这些修订反映了其对Exact Sciences Corporation的210亿美元重大收购的整合及其预期影响。该收购以前曾在雅培2025年的年度报告中披露。季度结果的发布与修订后的指导，特别是在重大并购事件之后，是投资者评估公司当前业绩和收购后未来财务轨迹的关键数据点。交易员将仔细检查详细的报告，以获取有关收益、收入和新指导范围的具体数据，以评估合并实体的财务健康状况和前景。

在该公告发布时，ABT的交易价格为$99.90，交易所为NYSE，所属行业为Life Sciences，市值约为$1768.8亿。 52周交易区间为$99.05至$139.06。 这则新闻被评估为中性市场情绪，重要性评分为7/10。 来源：Dow Jones Newswires。

show_chartPrice Chart

Share this article

Copied!

feed ABT - Latest Insights

ABT
Apr 17, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Abbott Laboratories Reaches Preliminary Settlement in Infant Formula Shareholder Derivative Lawsuits
Sentiment: Neutral
View Wiseek Article
ABT
Apr 16, 2026, 10:58 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Abbott Cuts Full-Year Outlook, Citing Mild Flu Season and Acquisition Impact
Sentiment: Negative
View Wiseek Article
ABT
Apr 16, 2026, 7:36 AM EDT
Filing Type: 8-K
Importance Score:
7
Abbott Reports In-Line Q1 Results, Updates FY26 Guidance Post-Exact Sciences Acquisition
Sentiment: Neutral
View Wiseek Article
ABT
Apr 16, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Abbott Reports Q1 2026 Results, Updates Guidance Reflecting Exact Sciences Acquisition
Sentiment: Neutral
View Wiseek Article
ABT
Mar 23, 2026, 9:03 AM EDT
Source: Wiseek News
Importance Score:
9
Abbott Completes $21 Billion Exact Sciences Acquisition, Bolstering Cancer Diagnostics
Sentiment: Positive
View Wiseek Article
ABT
Mar 23, 2026, 8:54 AM EDT
Filing Type: 8-K
Importance Score:
9
Abbott Completes $21 Billion Acquisition of Exact Sciences, Becomes Leader in Cancer Diagnostics
Sentiment: Positive
View Wiseek Article
ABT
Mar 13, 2026, 4:00 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Abbott Seeks Shareholder Approval for New Equity Plans Authorizing 9.0% Potential Dilution
Sentiment: Neutral
View Wiseek Article
ABT
Mar 09, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
8
Abbott Laboratories Completes $20 Billion Senior Notes Offering for Exact Sciences Acquisition
Sentiment: Neutral
View Wiseek Article
ABT
Mar 04, 2026, 6:00 AM EST
Source: Reuters
Importance Score:
7
Abbott Faces New Trial Over Infant Formula Causing Deadly Disease; Prior Verdicts Reached $495M
Sentiment: Negative
View Wiseek Article
ABT
Feb 25, 2026, 7:01 AM EST
Filing Type: 424B5
Importance Score:
9
Abbott Laboratories Finalizes $20 Billion Multi-Tranche Debt Offering to Fund Exact Sciences Acquisition
Sentiment: Neutral
View Wiseek Article